4587 — PeptiDream Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for PeptiDream, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,020	3,804	6,653	4,353	20,889
Depreciation
Amortisation
Non-Cash Items	1,226	412	220	311	613
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-6,084	1,806	-8,930	5,324	94.9
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,733	6,655	-82.9	12,421	23,845
Capital Expenditures	-586	-1,215	-3,975	-1,369	-2,218
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-614	-1,069	-23,402	2,672	10,589
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,200	-2,283	-27,377	1,303	8,371
Financing Cash Flow Items	—	21.5	-213	-38	18.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-237	66.1	20,789	264	-2,995
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	163	4,597	-6,499	14,260	28,610